NVRO
Nevro Corp
Halal Rating :
Last Price
$4.57
Last updated:
Market Cap
-
7D Change
13.4%
1 Year Change
-75.96%
Company Overview
Industries
Exchange
Next Earnings Date
Nevro Corp is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. The company develops and commercializes the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Their primary product, HFX™, is a comprehensive solution that includes a Senza spinal cord stimulation system and support services for the treatment of chronic pain.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $96.91m | $117.78m | - | $7.01m | 0.00% | 5.95% |
| June 30, 2024 | $104.16m | $136.02m | - | $6.74m | 0.00% | 4.96% |
| March 31, 2024 | $101.9m | $144.25m | - | $6.51m | 0.00% | 4.51% |
Company Impact
Help us evaluate Nevro Corp's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.